S&P 500 Consumer Staples Sector SEC Filings — May 14, 2026

14-05-2026

Apellis Pharmaceuticals, Inc. completed its acquisition by Biogen Inc. via tender offer and merger effective May 14, 2026, with shareholders receiving $41.00 per share in cash plus one non-transferable CVR potentially worth up to $4.00 upon milestone achievements. The company notified Nasdaq of the merger, halted trading, and plans to delist, deregister, and terminate SEC reporting obligations. Holders of the outstanding $93,897,000 principal amount of 3.500% Convertible Senior Notes due 2026 can elect to convert with a make-whole premium (yielding $1,080.77 cash and 26.3411 CVRs per $1,000 principal) until June 29, 2026, or require repurchase at 100% principal plus accrued interest (approx. $1,008.46 per $1,000) on June 30, 2026.

• · Base Conversion Rate: 25.3405 shares of Common Stock per $1,000 principal (standard); 26.3411 with Additional Shares of 1.0006 for Make-Whole Fundamental Change.
• · Make-Whole Fundamental Change Period: May 14, 2026 to June 29, 2026.
• · Fundamental Change Repurchase Date: June 30, 2026; repurchase at 100% principal plus accrued and unpaid interest.
• · Nasdaq trading halted effective before open on May 14, 2026; Form 25 to be filed for delisting.

14-05-2026

14-05-2026

14-05-2026

Signet Jewelers Limited (SIG) filed a DEFA14A definitive additional proxy statement on May 14, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing consists of additional materials related to the company's 2026 annual meeting proxy (cy2026annualmeetingproxyno.htm). No filing fee was required.

14-05-2026

Cellectar Biosciences reported positive 12-month follow-on data from the CLOVER-WaM Phase 2b study of iopofosine I 131 in r/r WM, achieving 61.8% major response rate, 83.6% overall response rate, median DoR of 17.8 months, and median PFS of 13.5 months, supporting plans for a Phase 3 confirmatory trial and FDA accelerated approval filing. The company completed a financing of up to $140 million ($35 million upfront plus $105 million milestone-based) led by Nantahala Capital, dosing first patients in CLR 125 Phase 1b for TNBC. Q1 2026 net loss improved to $5.7 million ($1.33/share) from $6.6 million ($4.30/share) YoY, with R&D and G&A expenses decreasing, though cash fell to $8.3 million from $13.2 million QoQ.

• · Phase 3 confirmatory study: randomized controlled with ~100 WM patients per arm, full enrollment in 18-24 months.
• · ASCO 2026 poster presentation on June 1, 2026, 9:00 AM – 12:00pm CDT (Poster 592).
• · Cash runway: adequate into Q2 2027 with May 2026 financing.
• · Median duration of response (DoR): 17.8 months; Median PFS: 13.5 months in CLOVER-WaM.

14-05-2026

Intelligent Bio Solutions Inc. reported fiscal Q3 2026 revenue of $1,060,802, up 46% YoY from $728,867, driven by cartridge sales growth of 59% to $703,538 (66% of revenue) and other sales up 80% to $217,857, though reader sales declined 16% to $139,407. Nine-month revenue reached $3,069,373, up 39% YoY from $2,208,648, with gross margins expanding to 50.5% in Q3 (from 46.8%) and 49.3% for the nine months (up 800 basis points). Despite revenue gains, Q3 net loss widened to $2,869,640 from $2,550,674, reflecting higher operating expenses.

• · Cash and cash equivalents increased to $6,862,204 at March 31, 2026 from $740,371 at December 31, 2025.
• · Total assets $14,862,792 at March 31, 2026, up from $8,249,786 at June 30, 2025.
• · Q3 operating loss $2,947,101, wider than $2,560,329 YoY.
• · Nine-month operating expenses $10,584,443, up from $8,917,114 YoY.

14-05-2026

FingerMotion, Inc., a Delaware corporation with operations in Singapore, entered into a Securities Purchase Agreement dated May 13, 2026, with certain buyers to issue and sell Notes in a private placement pursuant to Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D. The Closing is scheduled for no later than the second Business Day after execution, subject to satisfaction of conditions. The agreement includes representations confirming no material adverse effects since the latest financial statements, compliance with laws, valid intellectual property, adequate insurance, and no undisclosed liabilities or litigation with material impact.

• · Commission payable to Weild & Co for the transaction.
• · No brokerage or finder's fees payable to others.
• · Company address: 111 Somerset Road, Level 3, Singapore.

14-05-2026

Mitsui Sumitomo Insurance Co Ltd filed a 13F-HR on May 14, 2026, disclosing its holdings as of March 31, 2026. The filing reports ownership of 58,780,450 shares of W. R. Berkley Corporation common stock, valued at $3,895,968,226. No period-over-period changes or additional holdings are detailed in the filing.

• · Filing SEC file number: 028-26412
• · CUSIP for W. R. Berkley Corporation common stock: 084423102
• · Filer address: 9, Kanda Surugadai 3-Chome, Chiyoda-Ku, Tokyo 101-8011

14-05-2026

Reliance Global Group, Inc. filed Articles of Amendment to its Articles of Incorporation, implementing a 1-for-40 reverse stock split effective upon filing with the Florida Division of Corporations, reducing authorized Common Stock from 2,000,000,000 to 50,000,000 shares (97.5% reduction) and setting total authorized shares at 800,000,000 including 750,000,000 Preferred Stock shares. The amendment was adopted by the Board of Directors via unanimous written consent on May 7, 2026, without shareholder approval, with Nasdaq trading effective expected on May 18, 2026. No fractional shares will be issued; holders receive one whole share rounded up.

• · Articles adopted pursuant to Sections 607.1006, 607.10025, and 607.10025(7) of the Florida Business Corporation Act.
• · Signed on May 12, 2026.
• · Transfer agent authorized to round up fractional shares to one whole share.

14-05-2026

First International Bank of Israel Ltd., a subsidiary of F.I.B.I. Holdings Ltd., filed its 13F-HR on May 14, 2026, disclosing 59 U.S.-listed equity holdings as of March 31, 2026, primarily consisting of ETFs and select large-cap stocks. Significant positions include $38.2M in FIRST TR EXCHNG TRADED FD VI FT VEST US EQT (CUSIP 33740U679) and $28.9M in FIRST TR EXCHNG TRADED FD VI FT VEST US (CUSIP 33740F631), alongside stocks like Amazon.com Inc. ($5.6M) and Apple Inc. ($2.3M). The Bank manages these directly, through subsidiaries, or via HaBeinleumi Unique Portfolio Management Ltd. for clients, disclaiming any control group with its parent.

• · Securities reported are beneficially owned by the Bank, subsidiaries, or purchased by Unique on behalf of clients with investment discretion.
• · Filer and parent F.I.B.I. Holdings Ltd. operate under independent management with separate voting and investment decisions.
• · Includes only dual-listed securities on U.S. and Tel Aviv exchanges that were purchased in the U.S., per SEC guidance.
• · Business address: 42 Rothschild Blvd, Tel Aviv, L3 6688310, Israel

14-05-2026

Raphael Pharmaceutical Inc. reported a reduced net loss of $229 thousand for Q1 2026 (three months ended March 31, 2026), improving 47% YoY from $429 thousand, with R&D expenses down 49% to $37 thousand and G&A down 47% to $186 thousand. However, cash and equivalents sharply declined to $1 thousand QoQ from $45 thousand, leaving total assets at $3 thousand amid a 12% rise in current liabilities to $1,665 thousand driven by related-party payables. Stockholders' equity deficit worsened to $(1,662) thousand from $(1,433) thousand, signaling ongoing liquidity pressures.

• · Net cash used in operating activities improved to $44 thousand in Q1 2026 from $209 thousand in Q1 2025.
• · Weighted average shares used in EPS: 20,176,418 in Q1 2026 vs 19,626,418 in Q1 2025.
• · Basic and diluted net loss per share: $0.01 in Q1 2026 vs $0.02 in Q1 2025.
• · Entity is a small business, non-accelerated filer, incorporated in NV, operations in Tel Aviv, Israel.

14-05-2026

Elauwit Connection, Inc. reported Q1 2026 results with revenues declining 19% YoY to $4.4 million due to timing of client construction projects, gross profit falling to $0.8 million from $1.3 million, operating expenses rising to $3.0 million from $1.6 million, and net loss widening to $(2.2) million from $(0.4) million. However, billed units surged 114.8% YoY to 20,059, activated units increased 110.1% to 24,530, contracted units grew 29.4% to 36,720, and backlog more than doubled to $38.1 million from $15.6 million. The new sales team secured ~40 verbal awards for over 11,000 units across 14 ownership groups.

• · Cash and cash equivalents: $3.5 million as of March 31, 2026 (down from $6.2 million at Dec 31, 2025).
• · Accounts receivable: $3.2 million as of March 31, 2026.
• · Deferred revenue: $3.8 million as of March 31, 2026.
• · Related party debt: $1.2 million as of March 31, 2026.
• · Total assets: $9.9 million as of March 31, 2026 (down from $11.9 million at Dec 31, 2025).

14-05-2026

Sumitomo Mitsui Financial Group, Inc. filed its 13F-HR on May 14, 2026, disclosing institutional holdings as of March 31, 2026, across subsidiaries including Sumitomo Mitsui Banking Corporation and SMBC Nikko Securities Inc. The portfolio features large positions such as Ares Management Corporation ($1.458B), Jefferies Financial Group Inc. ($382M), SPDR Gold Trust ($254M), and Polestar Automotive ($190M), alongside ETFs and tech stocks like NVIDIA ($82M). No prior period data is provided for comparisons, with holdings including both common shares and options.

• · Filing period end date: March 31, 2026
• · Includes positions in call and put options on stocks like Uber Technologies, Qualcomm, and Verizon
• · Portfolio managed under multiple CIK numbers including 028-17794, 028-17800, 028-18879

14-05-2026

Pelthos Therapeutics reported Q1 2026 ZELSUVMI net product revenue of $10.7 million, up 17% QoQ from $9.1 million in Q4 2025, with units dispensed increasing 25% to 7,884 from 6,312 amid sales force expansion to 64 territory managers. However, SG&A expenses rose 14% to $21.1 million, interest expense doubled to $2.4 million, and net loss was $(10.2) million despite improvement from $(21.7) million in Q4 2025; cash stood at $32.0 million after drawing $30.0 million from a $50.0 million term loan facility.

• · Cost of goods sold remained flat at $1.7 million QoQ.
• · Entered $50.0 million senior secured term loan with Horizon Technology Finance in January 2026, drawing $30.0 million.
• · Conference call held May 14, 2026 at 8:30 a.m. ET.
• · Planned commercialization of XEPI® in early 2027 and XEGLYZE® in mid-2027.

14-05-2026

Chicago Atlantic BDC, Inc. reported first quarter 2026 results with total investment income of $16.7 million, up 17% QoQ from $14.2 million, net investment income of $10.0 million or $0.44 per share, up 20% QoQ from $0.36 per share, and a record investment portfolio of $364.0 million, up $30.7 million or 9% QoQ. The company funded $93.9 million across seven portfolio companies and declared a $0.34 per share dividend. However, net unrealized depreciation widened to $1.4 million due to credit spread widening, and total expenses rose 13% QoQ to $6.7 million.

• · No loans on non-accrual status as of March 31, 2026.
• · Principal amortization and repayments of $21.3 million during Q1 2026 (excluding refinance).
• · Shelf registration statement filed May 11, 2026, for up to $500 million of securities.
• · $50.0 million outstanding on senior credit facility as of May 13, 2026.

14-05-2026

NIQ reported Q1 2026 revenues of $1,072.7 million, up 11.1% YoY from $965.9 million, with strong growth in Americas (+13.6%) and EMEA (+13.2%), but APAC revenues declined slightly by 1.0%. Operating expenses increased to $1,082.9 million from $950.2 million, driven by higher restructuring ($64.9M vs $4.6M) and other costs, resulting in an operating loss of $10.2 million compared to a $15.7 million profit last year; net loss attributable to NIQ improved to $90.1 million from $119.8 million. Cash and equivalents fell to $362.3 million from $518.8 million at December 31, 2025, with net cash used in operating activities at $63.6 million versus $153.6 million prior year.

• · Restructuring expenses $64.9M in Q1 2026 vs $4.6M in Q1 2025.
• · Interest expense, net improved to $58.5M from $83.5M YoY.
• · Total assets $6,749.3M as of March 31, 2026 vs $6,802.0M as of Dec 31, 2025.
• · Long-term debt $3,473.5M as of March 31, 2026 vs $3,502.6M as of Dec 31, 2025.
• · NIQ shareholders' equity $915.9M as of March 31, 2026 vs $988.4M as of Dec 31, 2025.

14-05-2026

Deep Isolation Nuclear, Inc. reported Q1 2026 revenue of $1.4 million, down 5% YoY from $1.5 million, with net loss widening to $5.4 million from $0.2 million primarily due to R&D expenses of $3.5 million and SG&A expenses up 186% to $2.8 million. Operationally, the company launched a full-scale non-radioactive demonstration of its deep borehole technology, completed the ARPA-E ONWARDS project, and was selected for up to $20 million in ARPA-E SCALEUP Ready funding while making key leadership appointments. Cash position remained solid at $22.2 million as of March 31, 2026, up significantly from $2.2 million prior year.

• · SEC declared Form S-1 effective on May 7, 2026, allowing common stock to be freely tradable
• · Working with OTC Markets Group to trade on OTCQB exchange
• · Adjusted EBITDA of ($1.5) million for Q1 2026 vs ($0.1) million prior year
• · EBITDA of ($5.6) million for Q1 2026 vs ($0.1) million prior year

14-05-2026

Novak & Powell Financial Services, Inc. filed its 13F-HR report on May 14, 2026, disclosing 164 equity holdings totaling $185626233 as of March 31, 2026, all held with sole voting authority. The portfolio is diversified across individual stocks and ETFs, with top positions including Vanguard Growth ETF (25831 shares valued at $11282635), Apple Inc. (38991 shares valued at $9895505), and Vanguard Large-Cap ETF (28637 shares valued at $8558279). No other voting authority or discretion is reported.

• · Report period end: March 31, 2026
• · All 164 positions held as sole voting authority (SH SOLE)
• · No shared or other voting authority reported

14-05-2026

Candel Therapeutics reported a net loss of $8,861 thousand for the three months ended March 31, 2026, compared to net income of $7,379 thousand in the prior year period, driven by sharply higher operating expenses of $16,284 thousand (up 100% YoY) including R&D expenses of $9,840 thousand (up 145% YoY) and G&A of $6,444 thousand (up 57% YoY). Cash and cash equivalents increased to $194,834 thousand from $119,731 thousand at December 31, 2025 (up 63% QoQ), supported by $93,488 thousand net proceeds from a public stock offering. Total assets grew to $201,920 thousand, while net cash used in operating activities rose to $18,037 thousand (up 109% YoY).

• · Warrant liabilities decreased to $7,955 thousand from $15,598 thousand QoQ.
• · Term loan balance $46,428 thousand at March 31, 2026.
• · Stock-based compensation expense $1,579 thousand in Q1 2026.
• · Issuance costs for public offering $6.5 million.
• · Weighted-average remaining lease term 3.4 years.

14-05-2026

Non Invasive Monitoring Systems Inc (NIMU) reported a Q1 2026 net loss of $163 thousand, more than quadrupling from $39 thousand in Q1 2025, due to sharply higher general and administrative expenses of $144 thousand versus $23 thousand YoY, with no revenue generated. Cash improved to $24 thousand from $6 thousand QoQ (December 31, 2025), driven by $100 thousand in proceeds from related party notes payable, resulting in a net cash increase of $18 thousand. However, total liabilities rose 18.5% QoQ to $1,185 thousand, and shareholders' deficit widened to $1,159 thousand from $996 thousand.

• · No revenue reported for Q1 2026 or Q1 2025
• · Notes payable to related parties increased to $720 thousand from $620 thousand QoQ
• · Accrued interest to related parties increased to $209 thousand from $189 thousand QoQ
• · Basic and diluted loss per common share: $(0.00) for both Q1 2026 and Q1 2025

14-05-2026

Beeline Holdings reported Q1 2026 net revenue of $2.7 million, more than doubling YoY from approximately $1.35 million and up 7% sequentially, with loan originations surging 115% to $85.6 million across 288 loans versus $39.8 million across 128 loans in Q1 2025. Net loss narrowed 24% YoY to $5.3 million and Adjusted EBITDA loss improved 22% to $3.0 million, though operating expenses rose to $7.9 million (up 18% excluding stock-based compensation despite 116% revenue growth). The company ended the quarter with $1.9 million in cash, $50.9 million in shareholders’ equity, and no corporate debt, while advancing its BeelineEquity platform.

• · Precise net loss from reconciliation: $5,278 thousand (Q1 2026) vs. $6,927 thousand (Q1 2025).
• · Precise Adjusted EBITDA loss: $3,018 thousand (Q1 2026) vs. $3,847 thousand (Q1 2025).
• · Precise total operating expenses: $7,863 thousand (Q1 2026) vs. $6,004 thousand (Q1 2025).
• · BeelineEquity earns 3.5% per transaction plus title revenue with no balance sheet risk.
• · Conference call on May 14, 2026, at 5 p.m. ET.

14-05-2026

For the nine months ended March 31, 2026, MOVING iMAGE TECHNOLOGIES INC. reported net sales of $12,771, up 4.2% YoY from $12,264, with gross profit rising 19.3% YoY to $4,021; however, Q3 net sales declined 4.9% YoY to $3,397 from $3,571, and operating cash flow swung to a use of $3,301 from cash provided of $91 YoY. The company nearly broke even with a net loss of $1 versus $792 YoY, but cash balances dropped sharply 58.6% to $2,363 from $5,715, and total assets fell 18.8% to $8,842. Stockholders' equity edged up slightly to $4,882 from $4,857.

• · Equipment revenue (point in time) nine months: $12,630 vs $12,138 YoY (+4.1%)
• · Customer deposits declined to $270 from $1,101
• · Inventories increased to $3,180 from $2,066
• · Accounts payable decreased to $1,968 from $3,009

14-05-2026

Marnell Management LLC reported a portfolio of 72 equity positions totaling $287516986 as of March 31, 2026, in its quarterly 13F-HR filing submitted on May 14, 2026. Holdings are concentrated in shipping and maritime stocks (e.g., Star Bulk Carriers Corp at $9883578 for 430282 shares, Ardmore Shipping Corp at $4565194 for 299357 shares), cryptocurrency mining firms (e.g., Terawulf Inc at $9909976 for 686762 shares, CleanSpark Inc at $2164740 for 254376 shares), and protective put options on major ETFs (SPDR S&P 500 ETF at $84544200 for 130000 units, iShares iBoxx High Yield ETF at $19890000 for 250000 units). No performance changes or returns are disclosed in this snapshot filing.

• · Significant call option positions include DHT Holdings Inc ($4932900 for 270000 shares), Hafnia Ltd ($2279240 for 299900 shares), and TORM PLC ($5172660 for 185400 shares).
• · Portfolio features exposure to metals/mining (e.g., Cleveland-Cliffs Inc 39613 shares at $334730), bitcoin miners (e.g., Core Scientific Inc 170476 shares at $2550321), and REITs (e.g., JBG Smith PPTYS 451873 shares at $6601865).

14-05-2026

Osmosis Investment Management UK Ltd filed its 13F-HR on May 14, 2026, disclosing U.S. equity holdings as of March 31, 2026, totaling $3,722,467,766 across 456 positions, all with sole voting authority. The portfolio is heavily weighted toward large-cap technology stocks, with top holdings including Apple Inc ($240,539,878, 947,791 shares), Amazon.com Inc ($127,605,988, 612,695 shares), Alphabet Inc Class A ($101,651,597, 353,497 shares), Alphabet Inc Class C ($82,828,530, 288,742 shares), and Broadcom Inc ($76,158,031, 246,060 shares). No prior period data is included, providing a neutral snapshot of the firm's diversified investments.

• · All 456 positions held as SH SOLE (sole voting authority)
• · Firm's business address: 36-38 Botolph Lane, London X0 EC3R 8DE
• · SEC file number: 028-26333
• · Fiscal year end: 0331

14-05-2026

Elgethun Capital Management filed its 13F-HR on May 14, 2026, disclosing $604,617,722 in holdings as of March 31, 2026, across 166 positions, all held on a sole discretionary basis. Top holdings include Berkshire Hathaway Inc Del Cl B (132,203 shares valued at $63,351,757), Eli Lilly & Co (51,279 shares at $47,164,968), and Fairfax Financial (24,820 shares at $42,291,239). No period-over-period changes are detailed in this snapshot filing.

• · All 166 positions held as sole discretionary (SH SOLE)
• · Business address: 231 S Phillips Ave Suite 201, Sioux Falls, SD 57104
• · SEC file number: 028-17656
• · No other managers reported (0)

14-05-2026

Monolith Management Ltd filed its 13F-HR on May 14, 2026, for the period ended March 31, 2026, reporting 33 holdings with a total market value of $332021225. Top positions include Taiwan Semiconductor Manufacturing Co Ltd sponsored ADS at $49683719 (147015 shares), Alphabet Inc Class C at $40220354 (104209 shares), and Synopsys Inc at $32736560 (82568 shares). The portfolio features semiconductor and tech-heavy names, with notable call options on Alphabet Inc ($40734120) and State Street SPDR S&P Oil & Gas Expl & Prod ETF ($34547700).

• · Filing period end date: March 31, 2026
• · Filer address: 43/F, ROOM 33, CHAMPION TOWER, THREE GARDEN ROAD, CENTRAL, HONG KONG
• · All holdings reported as sole voting authority (SH SOLE)

14-05-2026

Steele Bancorp Inc reported robust YoY growth for Q1 2026 with net income surging 170% to $4,878 thousand and net interest income rising 158% to $12,210 thousand, bolstered by contributions from the prior acquisition of Mifflinburg Bancorp, Inc. Total assets increased 0.6% QoQ to $1,268,765 thousand, while deposits grew 0.4% QoQ to $1,115,201 thousand. However, loans declined slightly 0.1% QoQ to $916,899 thousand, noninterest expenses more than doubled YoY to $7,992 thousand, and other comprehensive loss included a $1,131 thousand unrealized holding loss on AFS debt securities.

• · Provision for credit losses recorded as recovery of $134 thousand in Q1 2026 vs provision of $7 thousand in Q1 2025
• · Core deposit intangible net $12,885 thousand as of March 31, 2026 (amortization $666 thousand in Q1)
• · Earnings per share basic and diluted $1.43 in Q1 2026 vs $0.97 in Q1 2025
• · Unrealized holding loss on AFS debt securities $1,131 thousand net of tax in Q1 2026

14-05-2026

Fieldview Capital Management, LLC filed its 13F-HR on May 14, 2026, disclosing 468 equity holdings totaling $342,580,172 as of March 31, 2026, all held with sole discretionary voting power. The portfolio spans diverse sectors including financials (e.g., AGNC Investment Corp at $1,882,491), real estate (e.g., Broadstone Net Lease Inc at $2,802,728), and technology (e.g., DLocal Ltd at $1,518,644). No prior period data is provided in the filing for comparison.

• · All 468 positions reported as SH SOLE with sole shares and no shared/other voting power.
• · Portfolio address: 2003 Morris Drive, Niles, MI 49120.
• · SEC file number: 028-25207; CIK: 0002040221.

14-05-2026

Delos Wealth Advisors, LLC disclosed its Q1 2026 13F-HR holdings totaling $174724008 across 260 positions, all held on a sole discretionary basis as of March 31, 2026. Notable positions include FIRST TR EXCHANGE-TRADED FD UTILITIES ALPH at $8105040 (163441 shares), FLEXSHARES TR IBOXX 3R TARGT at $4849988 (200082 shares), APPLE INC COM at $7144443 (28151 shares), and MICROSOFT CORP COM at $5417940 (14636 shares). No shared or other managed holdings were reported.

• · Filing submitted on May 14, 2026 for period ending March 31, 2026
• · All holdings reported as SOLE with no shared or other discretion positions
• · Business address: 1845 WOODALL RODGERS FWY, STE 1000, DALLAS TX 75201

14-05-2026

DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. filed its 13F-HR on May 14, 2026, reporting total holdings of $975,674,741 as of March 31, 2026, across 245 positions in equities, ETFs, calls, and puts. The portfolio includes significant allocations to fixed income and equity index derivatives, such as iShares MBS ETF ($49,725,315), SPDR S&P 500 ETF puts ($78,040,800), and SPDR S&P 500 ETF calls ($42,272,100), alongside individual stocks like Alibaba ($24,299,971). No period-over-period changes are disclosed in this filing.

• · SEC file number: 028-17414
• · Central Index Key: 0001672142
• · Investment adviser ID: 802-74548

14-05-2026

Morgan Stanley Institutional Investment Advisors LLC filed its 13F-HR on May 14, 2026, disclosing equity holdings as of March 31, 2026. Reported positions include Enbridge Inc valued at $402640437 with 7437023 shares held solely, Waste Management, Inc at $339922143 with 1479273 shares solely, and smaller holdings in Oceaneering ($122478102, 3453005 shares), National HealthCare Corporation ($165896999, 1038804 shares), and National Health Investors ($6217568, 76893 shares). No period-over-period changes or performance metrics are provided in the filing.

• · CUSIP for Enbridge Inc: 29250N105
• · Filing SEC file number: 028-24289
• · Filer EIN: 262924761
• · All holdings reported as SOLE with 0 shared, 0 other manager voting authority

14-05-2026

Clutterbuck Capital Management LLC filed its 13F-HR for the quarter ended March 31, 2026, disclosing holdings primarily under shared investment discretion (SH OTR) with Ancora Merlin Institutional, Ltd. and Ancora Merlin, LP. Key positions include NextNav common stock valued at $150,495,043,000 (9,300,806 shares), Seritage Class A valued at $1,551,112,000 (551,997 shares), Omeros Corp common stock valued at $3,168,000,000 (300,000 shares), and Omeros Corp 9.500% 6/1 notes valued at $8,900,815,000 (4,169,000 shares), alongside a smaller NextNav put options position valued at $33,825,000 (111 shares). No period-over-period changes or performance metrics are provided in the filing.

• · Filing date: May 14, 2026
• · Report period end: March 31, 2026
• · All positions reported as shared discretion (SH OTR) with other managers
• · Filer address: 200 Public Square Suite 2910, Cleveland, OH 44114
• · SEC file number: 028-26327

14-05-2026

Algorithmic Investment Models, LLC filed its 13F-HR report disclosing total equity holdings valued at $81,035,618 across 32 positions as of March 31, 2026. The portfolio is concentrated in Select Sector SPDR ETFs from State Street, with the top holdings being Energy ($6,947,886), Materials ($5,713,456), Health Care ($5,491,746), Consumer Staples ($5,481,027), and Utilities ($5,411,261). Other positions include ETFs from Invesco, Vanguard, iShares, and small stakes in individual stocks such as Elme Communities (11,734 shares), Gossamer Bio Inc (10,772 shares), and Fractyl Health Inc (15,500 shares).

• · Firm formerly known as Beaumont Capital Management, LLC (name change March 13, 2020).
• · All holdings reported as sole voting authority with no shared or other voting rights.
• · Firm address: 125 Newbury Street, 4th Floor, Boston, MA 02116.

14-05-2026

Santa Monica Partners LP filed its 13F-HR on May 14, 2026, reporting holdings as of March 31, 2026, with a total portfolio value of $179142 thousand across 13 positions held solely. Top holdings by value include Texas Pacific Land Corp. ($76866 thousand), Mastercard Incorporated ($51050 thousand), and Bel Fuse Inc. Class B ($13390 thousand). Other positions include small stakes like Berkshire Hathaway Inc. Class A (4 shares, $2873 thousand) and various Grayscale Bitcoin ETFs.

• · All holdings reported as SOLE voting authority with 0 shared or none.
• · Filing CIK: 0000904793, SEC File Number: 028-18447.

14-05-2026

Elkhorn Partners Limited Partnership filed its 13F-HR report on May 14, 2026, disclosing $157,075,878 in total holdings across 48 positions as of March 31, 2026, all held solely with no reported changes, puts, calls, or other voting authority. Top holdings include Kennedy-Wilson Holdings Inc (4,199,000 shares valued at $45,433,180), Berkshire Hathaway Inc Del Cl A (50 shares at $35,907,000), and Berkshire Hathaway Inc Del Cl B New (54,420 shares at $26,078,064). No period-over-period comparisons are available in this snapshot filing.

• · All positions held as sole discretionary with no reported shared voting authority, puts, or calls.
• · Filer CIK: 0000928400; SEC file number: 028-12336.
• · Business address: 8405 Indian Hills Drive, #2A8, Omaha, NE 68114.

14-05-2026

Knollwood Investment Advisory, LLC filed its 13F-HR on May 14, 2026, reporting 303 equity holdings valued at $991654121 as of March 31, 2026, all under sole discretionary management. Top positions include Amazon.com Inc ($43055449, 206729 shares), Apple Inc ($38026625, 149835 shares), Alphabet Inc Class C ($36455890, 127086 shares), and Microsoft Corp ($36062332, 97421 shares). The portfolio shows no changes or performance metrics compared to prior periods in this filing.

• · Report period end date: 2026-03-31
• · Filing date: 2026-05-14
• · All 303 holdings managed on a sole discretionary basis
• · Business address: 217 International Circle, Hunt Valley, MD 21030

14-05-2026

Mount Capital Ltd filed its Form 13F-HR on May 14, 2026, disclosing 18 equity holdings as of March 31, 2026, managed from its London office. Top positions by market value include Charles Schwab Corp at 43256926 USD, Wells Fargo Co at 34331494 USD, and Crown Hldgs Inc at 28571250 USD. Other significant holdings feature Charter Communications Inc N Cl A at 21298937 USD, Moderna Inc at 20076160 USD, and Liberty Broadband Corp Com Ser C at 18132396 USD.

• · All positions held with sole voting power (SH SOLE).
• · Filer CIK: 0001896379, SEC file number: 028-21717.

14-05-2026

Monte Financial Group, LLC filed its Form 13F-HR on May 14, 2026, disclosing 100 equity holdings as of March 31, 2026, with a total market value of $281,598,010. Top positions include Johnson & Johnson ($8,270,881), Chevron Corporation ($8,027,202), and RTX Corporation ($7,518,936), alongside other large-cap names like Wells Fargo & Co ($6,904,277) and Baker Hughes Company ($6,902,091). All holdings are reported with sole ownership and voting power; no period-over-period changes are provided in this filing.

• · Firm address: 30 Long Hill Road, Guilford, CT 06437
• · All positions held with sole voting power (SH SOLE); no shared power, put/call options, or other manager discretion reported
• · Portfolio includes ETFs such as iShares Core S&P 500 ETF and Fidelity Covington Trust sector index funds

14-05-2026

The Federal Home Loan Bank of Chicago reported the issuance of consolidated obligation bonds for which it is the primary obligor, with a total par value of $315,000,000 across five transactions traded on May 11-12, 2026. These fixed-rate callable bonds have maturities ranging from June 2027 to May 2031 and coupon rates from 3.875% to 4.580%, settled between May 13-22, 2026. The filing notes this is routine funding via capital markets, with no assessment of materiality for individual issuances and exclusions for short-term discount notes.

• · All bonds are Optional Principal Redemption type with Bermudan or European call styles.
• · Excludes discount notes with maturity of one year or less issued in ordinary course.
• · Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, not guaranteed by U.S. government.
• · Next call dates range from 2/12/2027 to 5/20/2027.

14-05-2026

SPG Advisors LLC filed a 13F-HR on May 14, 2026, disclosing its institutional holdings as of March 31, 2026, with a total portfolio value of $6,565,863 across 10 positions. Top holdings include Amazon.com Inc ($2,208,282 for 10,603 shares), Microsoft Corp ($1,190,119 for 3,823 shares), and Apple Inc ($624,453 for 2,461 shares). No prior period comparisons or changes in holdings are provided in the filing.

• · Other notable holdings: Berkshire Hathaway Inc ($330,648, 690 shares), Costco Wholesale Corporation ($535,491, 537 shares), Boeing Co ($208,583, 1,048 shares).
• · All positions reported as sole voting authority with no shared or performance shares.

14-05-2026

On May 14, 2026, Commonwealth Edison Company (ComEd) issued $600 million aggregate principal amount of First Mortgage 4.550% Bonds, Series 139, due June 1, 2031, and $825 million aggregate principal amount of First Mortgage 5.850% Bonds, Series 140, due June 1, 2056. Proceeds from the bonds will be used to redeem $500 million of its First Mortgage 2.550% Bonds, Series 120, due June 15, 2026, and for general corporate purposes. The issuance was made pursuant to ComEd's Mortgage dated July 1, 1923, as supplemented, and a Supplemental Indenture dated May 1, 2026.

• · Interest on the Bonds payable semi-annually on June 1 and December 1, commencing December 1, 2026.
• · Bonds redeemable at make-whole price prior to Series 139 Par Call Date (May 1, 2031) or Series 140 Par Call Date (December 1, 2055), and at par thereafter.
• · Underwriting Agreement dated May 7, 2026.
• · Registration Statement on Form S-3 (No. 333-284911-01) effective April 8, 2025.

14-05-2026

Peloton Wealth Strategists filed its 13F-HR on May 14, 2026, disclosing 86 equity holdings totaling $247247277 as of March 31, 2026, all held with sole voting authority. Top positions include Alphabet Inc. Cap Stk Cl A valued at $11353000 (39480 shares), Amazon.com Inc. Com at $8065000 (38725 shares), Mastercard Incorporated Cl A at $7267000 (14544 shares), and significant allocations to iShares iBonds ETFs and other large-cap stocks like Nike and Uber. No prior period comparisons are provided in the filing.

• · All 86 positions held as sole discretionary with no shared or other voting authority.
• · Significant exposure to fixed-income ETFs including iShares iBonds Dec 2028 Term Corporate ETF (399188 shares, $10111000) and Dec 2029 Term Corporate ETF (393645 shares, $9156000).

14-05-2026

RPG Investment Advisory, LLC filed its 13F-HR report disclosing total holdings valued at $829,041,374 across 92 positions as of March 31, 2026. The portfolio is diversified with top holdings including NVIDIA Corporation ($55,416,867), Alphabet Inc. Cap Stk Cl C ($40,953,855), Apple Inc. ($33,749,383), Amazon.com Inc. ($28,569,854), and Advanced Micro Devices Inc. ($22,778,667). All reported positions are held with sole voting power.

• · Report filed on May 14, 2026 for period ending March 31, 2026
• · All holdings reported with sole voting power (SH SOLE) and no shared power
• · Portfolio includes significant exposure to technology (e.g., NVIDIA, Apple), energy (e.g., Chevron, Exxon Mobil), and ETFs

14-05-2026

For Q1 2025, Cell Source, Inc. reported a net loss of $1,481,851, worsening 16% YoY from $1,275,406, driven by higher interest expenses despite a 12% reduction in operating expenses to $998,587. Cash balance plummeted 98% QoQ to $1,240 from $74,631 amid $600k cash burn from operations, partially offset by $527k from financing activities. Stockholders' deficiency deepened to $(20.1M) from $(18.5M) QoQ, with total liabilities rising 9% to $20.4M.

• · Liquidation preference Series A: $10,289,854 at March 31, 2025 (up from $10,066,463 at Dec 31, 2024)
• · Dividend attributable to preferred stockholders: $352,248 in Q1 2025 (up from $326,665 YoY)
• · Weighted average common shares: 45,038,244 in Q1 2025 (up from 40,507,352 YoY)

14-05-2026

Nutshell Asset Management Ltd, a London-based investment manager, filed its 13F-HR on May 14, 2026, disclosing total equity holdings of $184,051,869 across 35 positions as of March 31, 2026. The portfolio features significant concentrations in technology and software stocks, with top holdings including NVIDIA Corporation ($19,066,978 for 109,329 shares), Mastercard Incorporated ($15,760,775 for 31,543 shares), and Amphenol Corp ($15,442,244 for 122,218 shares). All positions are reported as solely owned, with one call option position in Intuit.

• · All holdings reported with sole voting and investment discretion (SH SOLE).
• · One put/call position: Intuit call options valued at $1,513,330 for 3,500 shares.
• · Holdings as of 2026-03-31; filed 2026-05-14.